Skip to content

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03074201
Enrollment
40
Registered
2017-03-08
Start date
2015-10-01
Completion date
2017-05-20
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary Obstruction, Choledocholithiasis

Keywords

ERCP, choledocholithiasis, cholangioscopy

Brief summary

Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP for non-complex bile duct stone disease.

Interventions

Cholangioscopy used instead of fluoroscopy-based ERCP to facilitate clearance of bile duct stones.

Cholangioscopy used instead of fluoroscopy-based ERCP to facilitate clearance of bile duct stones.

Sponsors

Boston Scientific Corporation
CollaboratorINDUSTRY
Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Intervention model description

Prospective feasibility study to evaluate potential for cholangioscopy to facilitate radiation-free ERCP.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age 18 and above 2. Non-complex biliary stone disease involving stones in the common bile or common hepatic duct. 3. Patient has undergone non-invasive imaging (abdo US, MRCP etc) which clearly delineates bile duct diameter and suggests non complex biliary stone disease. 4. Willing and able to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

1. Age \<18 2. Potentially vulnerable subjects including, homeless people, pregnant females, employees and students. 3. Participation in another related investigational study that could affect the results of this study within the previous 30 days 4. Complex biliary stone disease cases with unusual location of the stones (intra hepatic, cystic duct, stone proximal to bile duct stricture) 5. Known bile duct infection (cholangitis defined as ongoing fevers on the day of the ERCP procedure or purulence evident at the ampulla or bile duct on cannulation/sphincterotomy. If clear bile is aspirated during the study procedure, we will proceed according to study procedures. If purulence is detected upon aspiration of bile during the procedure, patient will be excluded from the study and undergo standard radiation-based ERCP rather than cholangioscopy.) 5\) Complex post-surgical anatomy e.g. Billroth type II anatomy, Roux-en-Y-gastrojejunostomy

Design outcomes

Primary

MeasureTime frameDescription
Stone clearanceDuring the cholangioscopy procedureSuccessful clearance of stones from the bile duct using cholangioscopy

Secondary

MeasureTime frameDescription
Procedure Duration5 minutes to 2.5 hours anticipated time frameDuration of procedure

Other

MeasureTime frameDescription
Adverse Eventsup to 30 weeks post-procedureEvaluation of adverse events following the procedure

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026